Antiatherogenic effects of the antioxidant BO-653 in three different animal models
AUTOR(ES)
Cynshi, Osamu
FONTE
The National Academy of Sciences
RESUMO
Antioxidants have been proposed to have antiatherogenic potential by their inhibition of low density lipoprotein (LDL) oxidation. Here, we report an antioxidant, BO-653 (2,3-dihydro-5-hydroxy-2,2-dipentyl-4,6-di-tert-butylbenzofuran), designed to exhibit antioxidative potency comparable to that of α-tocopherol, but yet possess a high degree of lipophilicity comparable to that of probucol. BO-653 exhibits a high affinity for LDL and is well distributed in aortic vessels in vivo. In atherosclerosis models of rabbits and mice, BO-653 has been shown to be able to suppress the formation of atherosclerotic lesions without untoward side effects. Specifically, there was no reduction of high density lipoprotein levels. This antioxidant provides additional evidence in support of the oxidized-LDL hypothesis, and itself is a promising candidate antioxidant for clinical use.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=21472Documentos Relacionados
- Comparison of the antioxidant potential of antiparkinsonian drugs in different in vitro models
- Effect of three animal models of inflammation on nerve fibres in the synovium.
- Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.
- Anti-atherogenic effects of fibrates in type 2 diabetes
- The mechanism of drug interactions of a selected antiarrhythmic drug with metformin, in different animal models